ID   GM17448
AC   CVCL_0R74
DR   CLO; CLO_0012848
DR   Coriell; GM17448
DR   Wikidata; Q54848884
RX   PubMed=26621101;
RX   PubMed=29474986;
RX   PubMed=31401124;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
RX   PubMed=26621101; DOI=10.1016/j.jmoldx.2015.08.005; PMCID=PMC4695224;
RA   Pratt V.M., Everts R.E., Aggarwal P., Beyer B.N., Broeckel U.,
RA   Epstein-Baak R., Hujsak P., Kornreich R., Liao J., Lorier R.,
RA   Scott S.A., Smith C.-Y.H., Toji L.H., Turner A., Kalman L.V.;
RT   "Characterization of 137 genomic DNA reference materials for 28
RT   pharmacogenetic genes: a GeT-RM collaborative project.";
RL   J. Mol. Diagn. 18:109-123(2016).
//
RX   PubMed=29474986; DOI=10.1016/j.jmoldx.2018.01.011;
RA   Pratt V.M., Del Tredici A.L., Hachad H., Ji Y., Kalman L.V.,
RA   Scott S.A., Weck K.E.;
RT   "Recommendations for clinical CYP2C19 genotyping allele selection: a
RT   report of the Association for Molecular Pathology.";
RL   J. Mol. Diagn. 20:269-276(2018).
//
RX   PubMed=31401124; DOI=10.1016/j.jmoldx.2019.06.007; PMCID=PMC6854474;
RA   Gaedigk A., Turner A., Everts R.E., Scott S.A., Aggarwal P.,
RA   Broeckel U., McMillin G.A., Melis R., Boone E.C., Pratt V.M.,
RA   Kalman L.V.;
RT   "Characterization of reference materials for genetic testing of CYP2D6
RT   alleles: a GeT-RM collaborative project.";
RL   J. Mol. Diagn. 21:1034-1052(2019).
//